266 related articles for article (PubMed ID: 23744508)
1. Progress on the research and development of inactivated EV71 whole-virus vaccines.
Liang ZL; Mao QY; Wang YP; Zhu FC; Li JX; Yao X; Gao F; Wu X; Xu M; Wang JZ
Hum Vaccin Immunother; 2013 Aug; 9(8):1701-5. PubMed ID: 23744508
[TBL] [Abstract][Full Text] [Related]
2. Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.
Li JX; Mao QY; Liang ZL; Ji H; Zhu FC
Expert Rev Vaccines; 2014 May; 13(5):609-18. PubMed ID: 24621093
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.
Zhou Y; Li JX; Jin PF; Wang YX; Zhu FC
Expert Rev Vaccines; 2016 Jul; 15(7):803-13. PubMed ID: 27206811
[TBL] [Abstract][Full Text] [Related]
4. Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial.
Xu Q; Cao Q; Yang W; Liu X; Liu H; Tian X; Li J; Fang X; Jia N; Zeng G; Xu A
Vaccine; 2020 Mar; 38(12):2671-2677. PubMed ID: 32067817
[TBL] [Abstract][Full Text] [Related]
5. Update on the development of enterovirus 71 vaccines.
Kung YA; Hung CT; Liu YC; Shih SR
Expert Opin Biol Ther; 2014 Oct; 14(10):1455-64. PubMed ID: 24989170
[TBL] [Abstract][Full Text] [Related]
6. 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.
Wei M; Meng F; Wang S; Li J; Zhang Y; Mao Q; Hu Y; Liu P; Shi N; Tao H; Chu K; Wang Y; Liang Z; Li X; Zhu F
J Infect Dis; 2017 Jan; 215(1):56-63. PubMed ID: 28077584
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu FC; Meng FY; Li JX; Li XL; Mao QY; Tao H; Zhang YT; Yao X; Chu K; Chen QH; Hu YM; Wu X; Liu P; Zhu LY; Gao F; Jin H; Chen YJ; Dong YY; Liang YC; Shi NM; Ge HM; Liu L; Chen SG; Ai X; Zhang ZY; Ji YG; Luo FJ; Chen XQ; Zhang Y; Zhu LW; Liang ZL; Shen XL
Lancet; 2013 Jun; 381(9882):2024-32. PubMed ID: 23726161
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018.
Han Y; Chen Z; Zheng K; Li X; Kong J; Duan X; Xiao X; Guo B; Luan R; Long L
Pediatr Infect Dis J; 2020 Oct; 39(10):969-978. PubMed ID: 32433221
[TBL] [Abstract][Full Text] [Related]
9. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
10. Development of enterovirus 71 vaccines.
Lee MS; Chang LY
Expert Rev Vaccines; 2010 Feb; 9(2):149-56. PubMed ID: 20109026
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus 71 vaccine: close but still far.
Zhang D; Lu J; Lu J
Int J Infect Dis; 2010 Sep; 14(9):e739-43. PubMed ID: 20400350
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.
Mao Q; Dong C; Li X; Gao Q; Guo Z; Yao X; Wang Y; Gao F; Li F; Xu M; Yin W; Li Q; Shen X; Liang Z; Wang J
PLoS One; 2012; 7(9):e46043. PubMed ID: 23029378
[TBL] [Abstract][Full Text] [Related]
13. Production of EV71 vaccine candidates.
Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
[TBL] [Abstract][Full Text] [Related]
14. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).
Mao QY; Wang Y; Bian L; Xu M; Liang Z
Expert Rev Vaccines; 2016 May; 15(5):599-606. PubMed ID: 26732723
[TBL] [Abstract][Full Text] [Related]
15. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
Klein MH
Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial.
Zhang W; Kong Y; Jiang Z; Li C; Wang L; Xia J
Hum Vaccin Immunother; 2016 Apr; 12(4):922-30. PubMed ID: 26837471
[TBL] [Abstract][Full Text] [Related]
18. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.
Chou AH; Liu CC; Chang CP; Guo MS; Hsieh SY; Yang WH; Chao HJ; Wu CL; Huang JL; Lee MS; Hu AY; Lin SC; Huang YY; Hu MH; Chow YH; Chiang JR; Chang JY; Chong P
PLoS One; 2012; 7(4):e34834. PubMed ID: 22529942
[TBL] [Abstract][Full Text] [Related]
19. EV71: an emerging infectious disease vaccine target in the Far East?
Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.
Sun S; Gao F; Mao Q; Shao J; Jiang L; Liu D; Wang Y; Yao X; Wu X; Sun B; Zhao D; Ma Y; Lu J; Kong W; Jiang C; Liang Z
Hum Vaccin Immunother; 2015; 11(10):2406-13. PubMed ID: 26036916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
